Dolby Laboratories Inc. (NYSE:DLB) insider Kevin J. Yeaman sold 22,102 shares of the stock in a transaction that occurred on Monday, October 10th. The stock was sold at an average price of $55.00, for a total transaction of $1,215,610.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Kevin J. Yeaman also recently made the following trade(s):

  • On Thursday, August 11th, Kevin J. Yeaman sold 3,287 shares of Dolby Laboratories stock. The stock was sold at an average price of $49.52, for a total transaction of $162,772.24.

Shares of Dolby Laboratories Inc. (NYSE:DLB) opened at 52.68 on Thursday. The firm’s 50-day moving average is $51.78 and its 200-day moving average is $48.08. Dolby Laboratories Inc. has a one year low of $30.38 and a one year high of $55.02. The stock has a market capitalization of $5.40 billion, a price-to-earnings ratio of 25.70 and a beta of 0.57.

Dolby Laboratories (NYSE:DLB) last announced its earnings results on Wednesday, July 27th. The company reported $0.76 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.51 by $0.25. The business earned $277.60 million during the quarter, compared to the consensus estimate of $268.04 million. Dolby Laboratories had a return on equity of 10.19% and a net margin of 20.19%. The business’s quarterly revenue was up 19.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.49 EPS. Equities research analysts forecast that Dolby Laboratories Inc. will post $1.79 EPS for the current year.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

A number of equities research analysts have commented on the stock. Dougherty & Co raised their target price on shares of Dolby Laboratories from $54.00 to $57.00 and gave the stock a “buy” rating in a research note on Thursday, July 28th. Zacks Investment Research cut shares of Dolby Laboratories from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, June 28th. JPMorgan Chase & Co. assumed coverage on shares of Dolby Laboratories in a research note on Tuesday, October 4th. They set a “neutral” rating and a $51.00 target price on the stock. Finally, B. Riley set a $50.00 target price on shares of Dolby Laboratories and gave the stock a “hold” rating in a research note on Thursday, July 28th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company. Dolby Laboratories currently has a consensus rating of “Hold” and a consensus price target of $50.80.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Walleye Trading LLC increased its position in shares of Dolby Laboratories by 155.8% in the second quarter. Walleye Trading LLC now owns 2,122 shares of the company’s stock valued at $102,000 after buying an additional 5,922 shares during the last quarter. BNP Paribas Arbitrage SA increased its position in shares of Dolby Laboratories by 13.9% in the second quarter. BNP Paribas Arbitrage SA now owns 2,901 shares of the company’s stock valued at $139,000 after buying an additional 353 shares during the last quarter. US Bancorp DE increased its position in shares of Dolby Laboratories by 17.2% in the second quarter. US Bancorp DE now owns 3,138 shares of the company’s stock valued at $150,000 after buying an additional 460 shares during the last quarter. Jackson Grant Investment Advisers Inc. acquired a new position in shares of Dolby Laboratories during the second quarter valued at $165,000. Finally, Advisor Group Inc. acquired a new position in shares of Dolby Laboratories during the second quarter valued at $166,000. 49.40% of the stock is owned by institutional investors and hedge funds.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio, imaging and communication technologies that transform entertainment and communications at the cinema, home, work and on mobile devices. The Company offers digital signal processing and compression technologies. Its technologies enable the development of the audio technologies for the cinema, home entertainment, mobile and gaming experiences.

5 Day Chart for NYSE:DLB

Receive News & Stock Ratings for Dolby Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories Inc. and related stocks with our FREE daily email newsletter.